GenMark Diagnostics To Present At The William Blair 36th Annual Growth Stock Conference

CARLSBAD, Calif.--(BUSINESS WIRE)--GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, announced today that Hany Massarany, President and Chief Executive Officer, will present at the William Blair 36th Annual Growth Stock Conference to be held in Chicago, Illinois at the Four Seasons Hotel on Wednesday, June 15, 2016 at 12:40 p.m. Central Time. The presentation will be made available at http://ir.genmarkdx.com.

ABOUT GENMARK DIAGNOSTICS

GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of automated, multiplex molecular diagnostic testing systems that detect and measure DNA and RNA targets to diagnose disease and optimize patient treatment. Utilizing GenMark’s proprietary eSensor^® detection technology, GenMark’s eSensor XT-8^® system is designed to support a broad range of molecular diagnostic tests with a compact, easy-to-use workstation and self-contained, disposable test cartridges. The eSensor detection technology is also incorporated into GenMark’s sample-to-answer system, ePlex^®. For more information, visit www.genmarkdx.com.